NeuroSense Therapeutics Ltd

NEW
FRA:H1Z (Israel)  
€ 0.57 (0%) Jul 2
At Loss
Market Cap:
€ 22.19M ($ 25.69M)
Enterprise V:
€ 22.45M ($ 25.70M)
Volume:
0
Avg Vol (2M):
738.00
Trade In:

NeuroSense Therapeutics Ltd Valuation Measures